about
ANCA-associated vasculitis in childhood: recent advances.Thrombosis in inflammatory bowel diseases: what's the link?Behçet's syndrome patients exhibit specific microbiome signature.Adalimumab effectiveness in Behçet's disease: short and long-term data from a multicenter retrospective observational study.A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study.A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis.The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third-level center in Italy.The protean ocular involvement in monogenic autoinflammatory diseases: state of the art.Macrophage activation syndrome in the course of monogenic autoinflammatory disorders.Certolizumab Pegol treatment in Behcet's disease with different organ involvement: A multicenter retrospective observational study.Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema.Management of Small Vessel Vasculitides.Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet's disease.Redox status alterations during the competitive season in élite soccer players: focus on peripheral leukocyte-derived ROS.Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study.Idiopathic Mediastinal Fibrosis: a Systemic Immune-Mediated Disorder. A Case Series and a Review of the Literature.Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study.Efficacy and safety of adalimumab in Behçet's disease-related uveitis: a multicenter retrospective observational study.Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome.Safety profile of biologic agents for Behçet's disease in a multicenter observational cohort study.Diagnostic Criteria for Adult-Onset Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome.Sharing data of clinical trials.Repeated low-dose courses of rituximab in SLE-associated antiphospholipid syndrome: Data from a tertiary dedicated centre.Auditory involvement in Behcet's disease: relationship with demographic, clinical, and therapeutic characteristics.SIRT1 activity is decreased in lesional psoriatic skin.Brief Report: Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein).Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet's Disease.Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up study.An immune-molecular hypothesis supporting infectious aetiopathogenesis of Kawasaki disease in children.Scheduled rituximab maintenance reduces relapse rate in eosinophilic granulomatosis with polyangiitis.β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome.Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related Uveitis.The Different Functional Distribution of "Not Effector" T Cells (Treg/Tnull) in Colorectal Cancer.A Biochemical Approach to Detect Oxidative Stress in Infertile Women Undergoing Assisted Reproductive Technology Procedures.Cutaneous sarcoidosis during rituximab treatment for microscopic polyangiitis: an uncommon adverse effect?Erythrocyte Membrane Fluidity Alterations in Sudden Sensorineural Hearing Loss Patients: The Role of Oxidative Stress.The Shc family protein adaptor, Rai, acts as a negative regulator of Th17 and Th1 cell development.Cytomegalovirus retinitis following intravitreal dexamethasone implant in a patient with central retinal vein occlusion.Comment on: First report of FIP1L1-PDGFRα-positive eosinophilic granulomatosis with polyangiitis: reply.Role of polymorphonucleates in the pathogenesis of systemic juvenile idiopathic arthritis and Still's disease: a proof of concept study.
P50
Q33644574-CD774505-4DD4-4A84-B312-CD97D185F33AQ35368162-BE9E905F-B81D-462C-B700-41EE9A0EE865Q35462057-6198E8C7-A461-4F7E-922A-8F5601CDAF9BQ36146582-973CBB1E-DCC7-4E81-9DCB-071B8E309550Q37361075-B7972428-D89E-47A7-9819-5F2B07ED6953Q37575470-9F76F999-D4E5-4B6E-A815-8BBBF014D60AQ38222307-7F2A8AEA-D7B5-428E-8718-68285BB94A09Q38400615-36738CE8-CB29-48B9-BD71-E45749B475B2Q38408014-37979EC5-6191-4649-9834-03744B000C9FQ38677010-45D027B2-4B6D-49B5-AE7B-72F83DC35F71Q38756600-7A33F747-935D-47E7-8BC2-03A43D850C2FQ38818682-5DD64B5C-4C14-4CBF-B310-9BBFEE834717Q38841182-F7668D13-CCB6-4758-B2FA-B6842B9B5D27Q38865510-C715FB03-0706-419B-A650-728E38BDA83AQ38904268-32BFD47F-DFE6-4698-AFA7-B095781A03FEQ38934972-4504AAA9-45F5-4DB3-AD21-F73AB46AB98BQ39096171-1F31CA9E-C9F9-4437-AEBC-FD22B812C643Q39181648-EE9DD4E5-6AA7-4EDB-9716-2288A26CAB76Q40105398-B5767A9F-3F4E-4E88-9A46-4B2AF23CC9AFQ40630984-0957A792-8D4A-44A0-917A-A98EA46C7AE7Q41881311-98865A19-7ABB-4575-81D4-20E916D9AA5BQ42697445-2BED78DB-39B0-4E56-900A-71237D70FC36Q44764615-74EDC356-9903-4818-87C3-AB9A11C485EBQ44899827-552688C1-9C01-4FBF-B10C-085553F85223Q46534382-4B284002-C98D-4ECE-B512-D639AA599516Q47705620-D4F110DF-9FFA-4085-A16F-855889FF4960Q47859067-D6FB1349-CAE6-4898-96B5-BBEDFB44527FQ48170980-BD68FE2D-5DAE-4E13-8E91-F9CA980DEFF5Q48203988-353FDE4F-8ABE-4027-BA8B-2B578285E9A3Q48229466-3FCDFEA8-92A4-44CD-935E-4B23D89280E5Q48243949-862F7ADB-C819-4D15-BDC3-157476AB6C44Q48368367-60334F90-965D-4D09-A4AE-7E8376FEB084Q49322680-D46CA032-F510-426E-956C-1A9AC532A701Q49805015-4BEB03BF-65DD-403D-BEEF-76BDFED06D7FQ49815749-8868758F-DDB0-4E8C-81E2-6B0F7887D72CQ50048414-CD142B7C-ABE4-410D-9A2F-F396B7FA44C3Q50917683-868F5C63-4EB7-497F-BB07-C30E24947B56Q50994910-675C60E3-D6D2-47B0-8062-ECFDCC97BCDEQ52897169-CAECD986-33C8-45AF-97FE-DF288EE5DBE0Q54337987-E3711661-CB95-47FC-AC20-9D15244731BC
P50
description
researcher ORCID ID = 0000-0001-9575-8321
@en
wetenschapper
@nl
name
Giacomo Emmi
@ast
Giacomo Emmi
@en
Giacomo Emmi
@es
Giacomo Emmi
@nl
type
label
Giacomo Emmi
@ast
Giacomo Emmi
@en
Giacomo Emmi
@es
Giacomo Emmi
@nl
prefLabel
Giacomo Emmi
@ast
Giacomo Emmi
@en
Giacomo Emmi
@es
Giacomo Emmi
@nl
P1153
35791709000
P21
P31
P496
0000-0001-9575-8321